Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Neo-adjuvant REGISTRY Trial Linking MammaPrint, Subtyping and Treatment Response: Neoadjuvant Breast Registry - Symphony Trial (NBRST) (Pronounced "in Breast")

NCT01479101 is registered in ClinicalTrials.gov with Agendia as lead sponsor.

NCT NCT01479101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01479101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Neo-adjuvant REGISTRY Trial Linking MammaPrint, Subtyping and Treatment Response: Neoadjuvant Breast Registry - Symphony Trial (NBRST) (Pronounced "in Breast")
Lead sponsor
Agendia
Phase
Observational
Overall status
Completed
Start date
July 31, 2011
Completion date
January 31, 2021
Enrollment
1,142 (actual)
Sites
76

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer